- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00575198
Drainage Amount for Removal of Thoracostomy Tube (DARTT)
Non-inferiority Randomized Trial Evaluating Removal of Thoracostomy Tubes Independent of the Drainage Amount Versus Removal When the Drainage Amount Is Low
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Thoracostomy tubes are routinely used to drain the pleural space of fluid and gas to optimize pulmonary mechanics. Clinicians frequently postpone removal of thoracostomy tubes if the drainage from the tube exceeds a specific volume threshold for the prior 24 hours. However, there is substantial variability in the drainage volume threshold that different clinicians use, and no threshold has been established as clearly superior to any other. Removing tubes independently of the drainage volume may result in a greater risk of pleural effusion or pneumothorax requiring an invasive drainage procedure. However, removing tubes independently of the drainage volume might also expedite recovery by allowing earlier removal of the tube, thus diminishing pain and increasing patient mobility.
Thoracostomy tube management practices, including the drainage volume threshold used, may be dissimilar for different types of disease processes, so this study will be restricted to patients who required a thoracostomy tube for treatment of traumatic injury.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- University of California, Davis, Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Thoracostomy tube in place for <72 hours
- Age at least 14 years
- Hospitalized for traumatic injury or elective operation
Exclusion Criteria:
- Thoracostomy tube already removed from the pleural cavity of interest
- Mediastinal tubes
- Death expected within 48 hours
- Prisoner status
- Severe congestive heart failure
- End-stage liver disease
- End-stage renal disease
- History of or suspected empyema involving the pleural cavity of interest
- History of or anticipated need for pleurodesis of the pleural cavity of interest
- Malignant pleural effusion
- Pregnancy
- Previous participation in this study
- Thoracostomy tube drainage already <2 mL/kg
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
No drainage threshold
|
Removal of the thoracostomy tube independently of the amount of fluid that drained from the tube in the prior 24 hours
|
|
Active Comparator: 2
Drainage <2 mL/kg
|
Removal of the thoracostomy tube only if the drainage from the tube in the prior 24 hours is less than 2 mL/kg of the patient's ideal body weight
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Invasive drainage procedure
Time Frame: Within 60 days
|
Within 60 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mortality
Time Frame: 60 days
|
60 days
|
|
Time to thoracostomy tube removal
Time Frame: Within 60 days
|
Within 60 days
|
|
Pulmonary symptoms
Time Frame: 60 days
|
60 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Garth H Utter, MD MSc, University of California, Davis
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200715709
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumothorax
-
Tabriz University of Medical SciencesAJA University of Medical SciencesUnknownPneumothorax, Spontaneous | Pneumothorax Spontaneous Primary | Pneumothorax, Recurrent | Pneumothorax Spontaneous TensionIran, Islamic Republic of
-
Peking University Third HospitalNot yet recruitingPrimary Spontaneous Pneumothorax
-
Rennes University HospitalRecruiting
-
Dow University of Health SciencesUnknownSecondary PneumothoraxPakistan
-
University Hospital, Strasbourg, FranceRecruiting
-
Chinese University of Hong KongRecruitingPneumothorax, SpontaneousHong Kong
-
Chung Shan Medical UniversityCompletedLung Nodules | Pneumothorax Iatrogenic Postprocedural | Propensity Score MatchingTaiwan
-
Johns Hopkins UniversityMedline Industries, IncCompletedPneumothorax | Tension PneumothoraxUnited States
-
University of RochesterWithdrawn
-
Ain Shams UniversityRecruitingPrimary and Secondary Spontaneous PneumothoraxEgypt
Clinical Trials on No drainage threshold
-
Prof A Gruca Teaching HospitalCompletedBleeding | Hip Osteoarthritis
-
University of British ColumbiaCompletedSpinal Cord InjuriesCanada
-
Jinling Hospital, ChinaActive, not recruiting
-
Bartosz PawełCompletedArthropathy of Hip
-
Zhongshan Hospital Xiamen UniversityUnknown
-
Second Affiliated Hospital, School of Medicine,...RecruitingDrainage | Thyroid CancerChina
-
Universidad Nacional Autonoma de HondurasRecruiting
-
Universidade Federal de GoiasAraujo Jorge HospitalCompletedBreast Cancer | Complications | SeromaBrazil
-
Mahidol UniversityEnrolling by invitationSurgical Site InfectionThailand
-
The Leeds Teaching Hospitals NHS TrustCompleted